Tissue engineered knee implant enters Spanish market
Madrid/Franklin Lakes - ReGen Biologics, Inc., a US orthopedic products company that develops, manufactures, and markets innovative tissue growth and repair products, has announced an exclusive two-year distribution agreement with Spanish-based Hoscenter to market the ReGen® CMI™ in most areas of Spain. The CMI is a type I collagen implant designed to facilitate growth of new tissue to replace removed or missing meniscus tissue in the human knee. Hoscenter will also market ReGen's SharpShooter® Tissue Repair System on a non-exclusive basis.
ReGen previously announced the establishment of a wholly owned subsidiary in Switzerland as well as a distribution partner for Italy.